Company intelligence / Profile preview
Axsome Therapeutics, Inc.
New York, New York, United Statesaxsometherapeuticsinc.gcs-web.com ↗
- Ownership
- Public · AXSM
- Development stage
- Commercial
01
Overview
Axsome has two commercial products (Auvelity for major depressive disorder and Sunosi for excessive daytime sleepiness) and a robust late-stage pipeline. Their lead candidate AXS-05 has shown positive results in three Phase 3 trials for Alzheimer's disease agitation with NDA submission planned for second half of 2025. AXS-12 showed positive Phase 3 results for narcolepsy in March 2024.
- Therapeutic areas
- PulmonologyPsychiatryNeurologyRheumatology
- Modalities
- Small moleculesNMDA receptor antagonistsDopamine and norepinephrine reuptake inhibitors
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
PharmanoviaSandoz Inc.Unichem Laboratories Ltd.
04
Financials
- Market cap
- $10.9B
- Total revenue
- $218.4M
- Enterprise value
- $10.8B
Beyond the preview
Go deeper on Axsome Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axsome Therapeutics, Inc..